Selective inhibition of leukotriene B4 formation by Ebselen: A novel approach to antiinflammatory therapy
- 1 January 1986
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 17 (3-4), 366-367
- https://doi.org/10.1007/bf01982648
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- A novel biologically active seleno-organic compound—IIIBiochemical Pharmacology, 1984
- A novel biologically active seleno-organic compound—IIBiochemical Pharmacology, 1984
- A novel biologically active seleno-organic compound—1Biochemical Pharmacology, 1984